RAC 2.92% $1.94 race oncology ltd

Industry news, page-1406

  1. 90 Posts.
    lightbulb Created with Sketch. 26
    Is there chance RAC has access to new data that you didn't which could allow them to abandon the observational trial without changing the interventional trial?

    (replying to @Davisite)
    Last edited by ReNova: 07/08/23
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.